Published by Global Banking & Finance Review®
Posted on August 19, 2025
1 min readLast updated: January 22, 2026
Add as preferred source on Google
Applied Nutrition's shares surged 12% as revenue forecasts for 2025 and 2026 exceeded market expectations, driven by global expansion.
(Reuters) -Shares of Applied Nutrition rose 12% on Tuesday after the British supplements maker forecast revenue for its fiscal year 2025 and 2026 to exceed market expectations amid global expansion.
The company, which went public in October 2024 in one of the largest London IPOs of that year, said it expects annual revenue to rise 24% to 107 million pounds ($144.61 million), above analysts' consensus of 100 million pounds, according to a company-compiled poll.
Applied Nutrition, which sells products in over 85 countries, has been expanding listings and shelf space in key retailers such as Asda and Tesco in the UK, its biggest market.
Revenue for the financial year ending July 2026 is also expected to surpass market expectation of 112.4 million pounds.
Shares of the company are on track for its best day since the IPO.
($1 = 0.7399 pounds)
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Harikrishnan Nair)
Shares of Applied Nutrition rose 12% on Tuesday after the company forecasted revenue exceeding market expectations.
The company expects its annual revenue to rise 24% to 107 million pounds ($144.61 million) for the fiscal year 2025.
Applied Nutrition is expanding its listings and shelf space in key retailers such as Asda and Tesco in the UK, its biggest market.
Applied Nutrition went public in October 2024 in one of the largest London IPOs of that year.
Revenue for the financial year ending July 2026 is expected to surpass the market expectation of 112.4 million pounds.
Explore more articles in the Finance category
